146 related articles for article (PubMed ID: 37626156)
1. Axillary lymph nodes enlargement after Sars-CoV-2 vaccine in patients undergoing breast examination: a single-centre experience in 285 women.
Marcon M; Catanese C; Scarano AL; Del Grande F; Manganiello M; Palermo M; Rizzo S
Radiol Med; 2023 Oct; 128(10):1217-1224. PubMed ID: 37626156
[TBL] [Abstract][Full Text] [Related]
2. COVID-19 Vaccine-Associated Subclinical Axillary Lymphadenopathy on Screening Mammogram.
Raj S; Ogola G; Han J
Acad Radiol; 2022 Apr; 29(4):501-507. PubMed ID: 34906409
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Vaccination Induced Lymphadenopathy in a Specialized Breast Imaging Clinic in Israel: Analysis of 163 cases.
Faermann R; Nissan N; Halshtok-Neiman O; Shalmon A; Gotlieb M; Yagil Y; Samoocha D; Friedman E; Sklair-Levy M
Acad Radiol; 2021 Sep; 28(9):1191-1197. PubMed ID: 34257025
[TBL] [Abstract][Full Text] [Related]
4. Axillary Lymphadenopathy after Pfizer-BioNTech and Moderna COVID-19 Vaccination: MRI Evaluation.
Yoshikawa T; Miki S; Nakao T; Koshino S; Hayashi N; Abe O
Radiology; 2023 Jan; 306(1):270-278. PubMed ID: 36098641
[TBL] [Abstract][Full Text] [Related]
5. Time for Resolution of COVID-19 Vaccine-Related Axillary Lymphadenopathy and Associated Factors.
Lane EG; Eisen CS; Drotman MB; Dodelzon K; Mema E; Thomas C; Prince MR
AJR Am J Roentgenol; 2022 Oct; 219(4):559-568. PubMed ID: 35583425
[No Abstract] [Full Text] [Related]
6. Axillary lymph node characteristics in breast cancer patients versus post-COVID-19 vaccination: Overview of current evidence per imaging modality.
van Nijnatten TJA; Jochelson MS; Lobbes MBI
Eur J Radiol; 2022 Jul; 152():110334. PubMed ID: 35512513
[TBL] [Abstract][Full Text] [Related]
7. Frequency and Characteristics of Nodal and Deltoid FDG and
Schroeder DG; Jang S; Johnson DR; Takahashi H; Navin PJ; Broski SM; Thorpe MP; Johnson GB; Young JR
AJR Am J Roentgenol; 2021 Nov; 217(5):1206-1216. PubMed ID: 34009000
[No Abstract] [Full Text] [Related]
8. Imaging of COVID-19 Vaccine-Related Axillary Lymphadenopathy: Initial Outcomes Based on US Features of Axillary Lymph Nodes.
Ahn RW; Porembka JH; Mootz AR; Goudreau SH; Dogan BE; Xi Y; Seiler SJ
J Breast Imaging; 2023 Mar; 5(2):135-147. PubMed ID: 38416930
[TBL] [Abstract][Full Text] [Related]
9. Unilateral Axillary Lymphadenopathy after the Inactivated SARS-COV-2 (CoronaVac) Vaccine: Ultrasonographic Imaging.
Elverici E; Özsoy A; Sayın B; Gökhan MB; Özkan E
Balkan Med J; 2023 Jan; 40(1):28-33. PubMed ID: 36421031
[TBL] [Abstract][Full Text] [Related]
10. [
Skawran S; Gennari AG; Dittli M; Treyer V; Muehlematter UJ; Maurer A; Burger IA; Mader C; Messerli O; Grünig H; Gebhard C; Huellner MW; Curioni-Fontecedro A; Berger C; Messerli M
Eur Radiol; 2022 Jan; 32(1):508-516. PubMed ID: 34156552
[TBL] [Abstract][Full Text] [Related]
11. Axillary Lymphadenopathy After a COVID-19 Vaccine Booster Dose: Time to Resolution on Ultrasound Follow-Up and Associated Factors.
Mema E; Lane EG; Drotman MB; Eisen CS; Thomas C; Prince MR; Dodelzon K
AJR Am J Roentgenol; 2023 Aug; 221(2):175-183. PubMed ID: 36883774
[No Abstract] [Full Text] [Related]
12. COVID-19 vaccine-related axillary lymphadenopathy in breast cancer patients: Case series with a review of literature.
Lim J; Lee SA; Khil EK; Byeon SJ; Kang HJ; Choi JA
Semin Oncol; 2021; 48(4-6):283-291. PubMed ID: 34836672
[TBL] [Abstract][Full Text] [Related]
13. US Evaluation of Axillary Lymphadenopathy Following COVID-19 Vaccination: A Prospective Longitudinal Study.
Ha SM; Chu AJ; Lee J; Kim SY; Lee SH; Yoen H; Cho N; Moon WK; Chang JM
Radiology; 2022 Oct; 305(1):46-53. PubMed ID: 35471107
[TBL] [Abstract][Full Text] [Related]
14. Detection of axillary lymphadenopathy after Covid-19 vaccination during breast examination: Case series and review of the literature after one year.
Veverková L; Mohelníková-Duchoňová B; Sedláčková Z; Löwová Ľ; Šišola I
Cent Eur J Public Health; 2023 Jun; 31(2):110-114. PubMed ID: 37451243
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinical factors and ultrasound features associated with COVID-19 vaccine-related axillary lymphadenopathy: A large group study.
Lim J; Khil EK; Lee SA; Choi JA; Lee KY; Jo SW; Lee J
Clin Imaging; 2024 Jan; 105():110046. PubMed ID: 38039749
[TBL] [Abstract][Full Text] [Related]
16. Fine needle aspiration in COVID-19 vaccine-associated lymphadenopathy.
Hagen C; Nowack M; Messerli M; Saro F; Mangold F; Bode PK
Swiss Med Wkly; 2021 Jul; 151():w20557. PubMed ID: 34286849
[TBL] [Abstract][Full Text] [Related]
17. FDG PET/CT radiomics as a tool to differentiate between reactive axillary lymphadenopathy following COVID-19 vaccination and metastatic breast cancer axillary lymphadenopathy: a pilot study.
Eifer M; Pinian H; Klang E; Alhoubani Y; Kanana N; Tau N; Davidson T; Konen E; Catalano OA; Eshet Y; Domachevsky L
Eur Radiol; 2022 Sep; 32(9):5921-5929. PubMed ID: 35385985
[TBL] [Abstract][Full Text] [Related]
18. The location of unilateral axillary lymphadenopathy after COVID-19 vaccination compared with that of metastasis from breast cancer without vaccination.
Mukai K; Tsunoda H; Imai R; Numata A; Kida K; Oba K; Yagishita K; Yamauchi H; Kanomata N; Kurihara Y
Jpn J Radiol; 2023 Jun; 41(6):617-624. PubMed ID: 36626076
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 mRNA Vaccination Causes Prolonged Increased Cortical Thickening and Vascularity in Ipsilateral Axillary Lymph Nodes.
Teefey SA; Middleton WD; Turner JS; Ellebedy AH; Suessen T; Wallendorf M; O'Halloran JA; Presti R
J Ultrasound Med; 2022 Nov; 41(11):2849-2858. PubMed ID: 35257401
[TBL] [Abstract][Full Text] [Related]
20. Unilateral axillary Adenopathy in the setting of COVID-19 vaccine.
Mehta N; Sales RM; Babagbemi K; Levy AD; McGrath AL; Drotman M; Dodelzon K
Clin Imaging; 2021 Jul; 75():12-15. PubMed ID: 33486146
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
